Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society International Conference Committee says that even though there are strides to be made in pediatric pulmonology, treatments for children with diseases, such as cystic fibrosis, have improved.
Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital, says that since sleep disorders are common, it’s important to consider that sleep can be a separate symptom from epilepsy.
A range of posters presented at the 2023 American Thoracic Society (ATS) International Conference highlighted a plethora of risk factors for pulmonary conditions in adulthood outside of tobacco smoking history.
A symposium at the 2023 American Thoracic Society International Conference highlighted common comorbidities that warrant consideration in patients who present with chronic obstructive pulmonary disease (COPD).
Franco Laghi, MD, a professor and pulmonologist affiliated with Loyola University Medical Center as well as the Edward Hines, Jr. Veterans Affairs Hospital in Maywood, Illinois, discussed the use of home-based exercise rehabilitation programs for veterans with long COVID-19, and patient reluctance to come to a medical facility during the pandemic.
Chitra Lal, MD, D-ABSM, FCCP, FAASM, FACP, ATSF, professor of medicine at Medical University of South Carolina, talks about how there might be a link between obstructive sleep apnea (OSA) and Alzheimer disease (AD), and that treating sleep apnea early and aggressively may help prevent AD development.
A symposium at the 2023 American Thoracic Society (ATS) International Conference featured research on predictors of chronic obstructive pulmonary disease (COPD) occurrence and disease progression.
Anna E. Mullins, PhD, assistant professor at the Icahn School of Medicine at Mount Sinai, discusses the necessity of awareness of how health issues can present in World Trade Center (WTC) responders.
Posters presented at the 2023 American Thoracic Society International Conference called for improvements in care for chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.
Gerard Criner, MD, FACP, FACCP, professor and founding chair, Thoracic Medicine and Surgery, at the Lewis Katz School of Medicine at Temple University, discusses a new trial that investigated how long treatment would last for patients with emphysema, and if any complications arose.
At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, the strategy advancement lead at Humana talked more about Humana’s health equity strategy and areas that pharmacy benefit managers (PBMs) and health plans can influence.
Quantifying social determinants of health and addressing the factors that allow disparities to persist will require standardized measurements and targeted interventions, said a panel of experts at the 2023 American Thoracic Society International Conference.
Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society (ATS) International Conference Committee, highlights the need for more specialized care and research for children with respiratory diseases, who don't have access to the same therapies and testing as adults.
Rupal Shah, MD, associate professor at the University of California San Francisco, talks about how the onset of the COVID-19 pandemic created an opportunity for patients who have undergone a lung transplant to undergo spirometry testing at home instead of at the the hospital.
In the phase 3 BOREAS study of patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, patients treated with dupilumab experienced fewer COPD exacerbations, improved lung function, and improved quality of life compared with patients given a placebo.
Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai, talks about how autonomic neuropathy in people with HIV needs more study.
Pharmacists at the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting discussed the role of data collection and analysis in the movement toward health equity.
Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital, talks about how factors such as the sedative effects of anti-epileptic medications can mask sleep issues and diagnoses in people with epilepsy.
This year’s American Thoracic Society (ATS) International Conference will spotlight not only the latest research in respiratory medicine, but also timely themes such as minority health equity, the effects of climate on health, and reducing gun violence through advocacy.
Horace DeLisser, MD, associate dean for diversity and inclusion in undergraduate medical education at the Perelman School of Medicine at the University of Pennsylvania and associate professor of medicine in the pulmonary, allergy, and critical care division, looks forward to the American Thoracic Society (ATS) international conference to reconnect with friends and colleagues and stay up to date on clinical knowledge and controversial topics.
A panel of top practice administrators, moderated by Danielle Geiger, APRN-NP, of Nebraska Cancer Specialists, explored ways for practices to improve the bottom line at the Quality Cancer Care Alliance (QCCA) spring conference, held April 19-21, 2023.
At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).
Elizabeth Johnson, LPN, PACS, BPCA, CEO of MedicoCX, co-CEO of Healthcare Advocate Summit, and an Asembia 2023 presenter, discusses why more empathetic approaches that take into account the full range of the patient experience are needed to improve patient-focused health care.
Panelists from Optum Life Sciences, OptumRx, and Takeda discussed the importance of collaboration in creating successful value-based agreements (VBAs) at Asembia 2023.
The American Journal of Managed Care® interviewed 2 presenters at Asembia 2023, gaining insight on how the specialty pharmacy pipeline is growing and how health systems and payers can affect the accessibility and affordability of new specialty therapies.
Jessica Robinson-Papp, MD, MS, professor of neurology at the Icahn School of Medicine at Mount Sinai, talks about the strides made in antiretroviral therapy for HIV and how these improvements lead to better patient outcomes.
Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital, says that sleep apnea is more common in men until after women experience menopause.
“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.
Speakers at the 2023 Asembia Specialty Pharmacy Summit outlined how artificial intelligence (AI) tools for pharmaceuticals, such as parcel tracking, could reduce operational costs for specialty pharmacies and mitigate drug delivery issues for patients.
Milena Pavlova, MD, neurologist, and medical director of the Sleep Testing Center at Brigham and Women’s Faulkner Hospital, highlights how even mild cases of sleep apnea can increase the number of seizures a patient with epilepsy experiences and harm organs.
